Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature.
Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19.
PUVA for cutaneous T-cell lymphoma. 10 years after.
Integrative genome modeling platform reveals essentiality of rare contact events in 3D genome organizations.
Time to tumor growth: a model end point and new metric system for oncology clinical trials.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Ji, Yuan
One or more keywords matched the following items that are connected to
Ji, Yuan
Item Type
Name
Concept
Clinical Trials, Phase I as Topic
Concept
Randomized Controlled Trials as Topic
Concept
Clinical Trials, Phase II as Topic
Concept
Controlled Clinical Trials as Topic
Concept
Clinical Trials as Topic
Academic Article
Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios.
Academic Article
Adaptive randomization for multiarm comparative clinical trials based on joint efficacy/toxicity outcomes.
Academic Article
Dose--schedule finding in phase I/II clinical trials using a Bayesian isotonic transformation.
Academic Article
Dose-finding in phase I clinical trials based on toxicity probability intervals.
Academic Article
A modified toxicity probability interval method for dose-finding trials.
Academic Article
Modified toxicity probability interval design: a safer and more reliable method than the 3 + 3 design for practical phase I trials.
Academic Article
An integrated dose-finding tool for phase I trials in oncology.
Academic Article
Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data.
Academic Article
A decision-theoretic phase I-II design for ordinal outcomes in two cycles.
Academic Article
TEAMS: Toxicity- and Efficacy-based Dose Insertion Design with Adaptive Model Selection for Phase I/II Dose-Escalation Trials in Oncology.
Academic Article
A Bayesian Dose-finding Design for Oncology Clinical Trials of Combinational Biological Agents.
Academic Article
Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials.
Academic Article
Structured clinical documentation in the electronic medical record to improve quality and to support practice-based research in epilepsy.
Academic Article
Subgroup-Based Adaptive (SUBA) Designs for Multi-Arm Biomarker Trials.
Academic Article
A Bayesian interval dose-finding design addressingOckham's razor: mTPI-2.
Academic Article
Design and implementation of pragmatic clinical trials using the electronic medical record and an adaptive design.
Academic Article
R-TPI: rolling toxicity probability interval design to shorten the duration and maintain safety of phase I trials.
Academic Article
AAA: triple adaptive Bayesian designs for the identification of optimal dose combinations in dual-agent dose finding trials.
Academic Article
The i3+3 design for phase I clinical trials.
Academic Article
RoBoT: a robust Bayesian hypothesis testing method for basket trials.
Academic Article
Variants in STAT4 Associated With Cure of Chronic HBV Infection in HBeAg-positive Patients Treated With Pegylated Interferon-alpha.
Academic Article
Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample size.
Academic Article
Monitoring late-onset toxicities in phase I trials using predicted risks.
Academic Article
Discussion of "A hybrid phase I-II/III clinical trial design allowing dose re-optimization in phase III" by Andrew G. Chapple and Peter F. Thall.
Grant
Bayesian Inference for Tumor Heterogeneity with Next-Generation Sequencing Data
Academic Article
Bayesian Adaptive Design for Finding the Maximum Tolerated Sequence of Doses in Multicycle Dose-Finding Clinical Trials.
Academic Article
Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angioma.
Academic Article
A Multi-Arm Two-Stage (MATS) design for proof-of-concept and dose optimization in early-phase oncology trials.
Search Criteria
Clinical
Trials